Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marla C Dubinsky

Showing results (171-180 of 286) with videos related to

Pageof 29
Sort By:
Inflammatory Bowel Diseases|July 9, 2018
Outcomes of Pregnancies With Maternal/Paternal Exposure in the Tofacitinib Safety Databases for Ulcerative ColitisUma Mahadevan, Marla C Dubinsky, Chinyu Su, et al.
BMJ Open Gastroenterology|March 31, 2023
Changes in health-related quality of life and associations with improvements in clinical efficacy: a Phase 2 study of mirikizumab in patients with ulcerative colitisMarla C Dubinsky, Vipul Jairath, Brian G Feagan, et al.
The American Journal of Gastroenterology|April 8, 2011
An evidence-based systematic review on medical therapies for inflammatory bowel diseaseNicholas J Talley, Maria T Abreu, Jean-Paul Achkar, et al.
Inflammatory Bowel Diseases|March 8, 2016
Efficacy and Safety of Escalation of Adalimumab Therapy to Weekly Dosing in Pediatric Patients with Crohn's DiseaseMarla C Dubinsky, Joel Rosh, William A Faubion, et al.
Inflammatory Bowel Diseases|December 17, 2009
Genome wide association (GWA) predictors of anti-TNFalpha therapeutic responsiveness in pediatric inflammatory bowel diseaseMarla C Dubinsky, Ling Mei, Madison Friedman, et al.
Inflammatory Bowel Diseases|August 21, 2023
The Communicating Needs and Features of IBD Experiences (CONFIDE) Study: US and European Patient and Health Care Professional Perceptions of the Experience and Impact of Symptoms of Moderate-to-Severe Ulcerative ColitisSimon Travis, Alison Potts Bleakman, Marla C Dubinsky, et al.
Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract|March 13, 2023
Emergent Subtotal Colectomies Have Higher Leak Rates in Subsequent J-Pouch StagesMichael C Plietz, Marine Coste, Jeremy Miller, et al.
The American Journal of Gastroenterology|January 19, 2005
Safety and efficacy of adalimumab (D2E7) in Crohn's disease patients with an attenuated response to infliximabKonstantinos A Papadakis, Omid A Shaye, Eric A Vasiliauskas, et al.
Crohn'S & Colitis 360|February 13, 2023
Performance Characteristics of a Clinical Decision Support Tool for Disease Complications in Crohn's DiseaseCorey A Siegel, Lori S Siegel, Marla C Dubinsky, et al.
BMC Gastroenterology|February 20, 2022
Objective disease activity assessment and therapeutic drug monitoring prior to biologic therapy changes in routine inflammatory bowel disease clinical practice: TARGET-IBDBenjamin Click, Edward L Barnes, Benjamin L Cohen, et al.
Pageof 29

Showing results (171-180 of 286) with videos related to

Sort By:
Pageof 29
Inflammatory Bowel Diseases|July 9, 2018
Outcomes of Pregnancies With Maternal/Paternal Exposure in the Tofacitinib Safety Databases for Ulcerative ColitisUma Mahadevan, Marla C Dubinsky, Chinyu Su, et al.
BMJ Open Gastroenterology|March 31, 2023
Changes in health-related quality of life and associations with improvements in clinical efficacy: a Phase 2 study of mirikizumab in patients with ulcerative colitisMarla C Dubinsky, Vipul Jairath, Brian G Feagan, et al.
The American Journal of Gastroenterology|April 8, 2011
An evidence-based systematic review on medical therapies for inflammatory bowel diseaseNicholas J Talley, Maria T Abreu, Jean-Paul Achkar, et al.
Inflammatory Bowel Diseases|March 8, 2016
Efficacy and Safety of Escalation of Adalimumab Therapy to Weekly Dosing in Pediatric Patients with Crohn's DiseaseMarla C Dubinsky, Joel Rosh, William A Faubion, et al.
Inflammatory Bowel Diseases|December 17, 2009
Genome wide association (GWA) predictors of anti-TNFalpha therapeutic responsiveness in pediatric inflammatory bowel diseaseMarla C Dubinsky, Ling Mei, Madison Friedman, et al.
Inflammatory Bowel Diseases|August 21, 2023
The Communicating Needs and Features of IBD Experiences (CONFIDE) Study: US and European Patient and Health Care Professional Perceptions of the Experience and Impact of Symptoms of Moderate-to-Severe Ulcerative ColitisSimon Travis, Alison Potts Bleakman, Marla C Dubinsky, et al.
Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract|March 13, 2023
Emergent Subtotal Colectomies Have Higher Leak Rates in Subsequent J-Pouch StagesMichael C Plietz, Marine Coste, Jeremy Miller, et al.
The American Journal of Gastroenterology|January 19, 2005
Safety and efficacy of adalimumab (D2E7) in Crohn's disease patients with an attenuated response to infliximabKonstantinos A Papadakis, Omid A Shaye, Eric A Vasiliauskas, et al.
Crohn'S & Colitis 360|February 13, 2023
Performance Characteristics of a Clinical Decision Support Tool for Disease Complications in Crohn's DiseaseCorey A Siegel, Lori S Siegel, Marla C Dubinsky, et al.
BMC Gastroenterology|February 20, 2022
Objective disease activity assessment and therapeutic drug monitoring prior to biologic therapy changes in routine inflammatory bowel disease clinical practice: TARGET-IBDBenjamin Click, Edward L Barnes, Benjamin L Cohen, et al.
Pageof 29